Titan Pharmaceuticals, Inc. (TTNP) NASDAQ
2.34
-0.3(-11.36%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.93M |
| Enterprise Value | 99,740 |
| P/E Ratio | 17.09 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 2.68 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 282.8 |
| Enterprise/EBITDA | 2,647.9 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.08 |
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0.7 |
| Gross Profit | -5,000 |
| EBITDA | -4.7M |
| Net Income | -4.71M |
| Diluted EPS | -5.23 |
Balance Sheet
| Total Cash | 1.96M |
| Total Cash/Share | 19.2 |
| Total Debt | 0 |
| Total Debt/Equity | 0.04 |
| Current Ratio | 0.3 |
| Book Value Per Share | 5,155.43 |
Price History
| 52-Week Change | -28.66 |
| 52-Week High | 15.15 |
| 52-Week Low | 2.33 |
| Moving Average 50 Days | 4.38 |
| Moving Average 200 Days | 4.05 |
Statistics
| Average Volume | 129,772 |
| Shares Outstanding | 1.33M |
| % Held by Institutions | 0.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | January 09, 2024 |
